Log in
Enquire now
‌

US Patent 7723289 PIF tetrapeptides

Patent 7723289 was granted and assigned to Bioincept on May, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Bioincept
Bioincept
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
77232890
Patent Inventor Names
Eytan R. Barnea0
Date of Patent
May 25, 2010
0
Patent Application Number
111109900
Date Filed
April 20, 2005
0
Patent Primary Examiner
‌
Michael Szperka
0
Patent abstract

Peptides and peptidomimetics capable of enhance endometrial receptivity, blocking activated but not basal immunity, inhibiting cell proliferation and creating a TH2 type cytokine bias are disclosed. The peptides and mimetics are based upon the C-terminal tetrapeptide of PIF peptides. Also disclosed are methods of using these peptides and peptidomimetics for therapeutic and diagnostic purposes.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7723289 PIF tetrapeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.